ASCO 2018
ASCO 2018/ ASCO 2018/ Insights/ Oncology/ Video
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success
Richard Staines
asco, Bayer, clinical trial, Eisai, Gary Hendler, Lenvima, Liver cancer, Oncology, REFLECT study
0 Comment
X
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success
https://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/